These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38272563)

  • 61. Chordoma of the skull base: predictors of tumor recurrence.
    Pallini R; Maira G; Pierconti F; Falchetti ML; Alvino E; Cimino-Reale G; Fernandez E; D'Ambrosio E; Larocca LM
    J Neurosurg; 2003 Apr; 98(4):812-22. PubMed ID: 12691407
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tumor-Infiltrating B- and T-Cell Repertoire in Pancreatic Cancer Associated With Host and Tumor Features.
    Pineda S; López de Maturana E; Yu K; Ravoor A; Wood I; Malats N; Sirota M
    Front Immunol; 2021; 12():730746. PubMed ID: 34630409
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Higher cMET dependence of sacral compared to clival chordoma cells: contributing to a better understanding of cMET in chordoma.
    Lohberger B; Scheipl S; Heitzer E; Quehenberger F; de Jong D; Szuhai K; Liegl-Atzwanger B; Rinner B
    Sci Rep; 2021 Jun; 11(1):12466. PubMed ID: 34127734
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Molecular and clinical risk factors for recurrence of skull base chordomas: gain on chromosome 2p, expression of brachyury, and lack of irradiation negatively correlate with patient prognosis.
    Kitamura Y; Sasaki H; Kimura T; Miwa T; Takahashi S; Kawase T; Yoshida K
    J Neuropathol Exp Neurol; 2013 Sep; 72(9):816-23. PubMed ID: 23965741
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Autophagic Markers in Chordomas: Immunohistochemical Analysis and Comparison with the Immune Microenvironment of Chordoma Tissues.
    Karpathiou G; Dridi M; Krebs-Drouot L; Vassal F; Jouanneau E; Jacquesson T; Barrey C; Prades JM; Dumollard JM; Meyronet D; Boutonnat J; Péoc'h M
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33946484
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Leukemia Inhibitory Factor Promotes Aggressiveness of Chordoma.
    Gulluoglu S; Sahin M; Tuysuz EC; Yaltirik CK; Kuskucu A; Ozkan F; Sahin F; Ture U; Bayrak OF
    Oncol Res; 2017 Aug; 25(7):1177-1188. PubMed ID: 28247842
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Analysis of prognostic factors for survival in patients with primary spinal chordoma using the SEER Registry from 1973 to 2014.
    Pan Y; Lu L; Chen J; Zhong Y; Dai Z
    J Orthop Surg Res; 2018 Apr; 13(1):76. PubMed ID: 29625617
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Primary chordomas of the cervical spine: a consecutive series of 14 surgically managed cases.
    Wang Y; Xiao J; Wu Z; Huang Q; Huang W; Zhu Q; Lin Z; Wang L
    J Neurosurg Spine; 2012 Oct; 17(4):292-9. PubMed ID: 22920610
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Frequency and Risk Factors for Additional Lesions in the Axial Spine in Subjects With Chordoma: Indications for Screening.
    Sebro R; DeLaney TF; Hornicek F; Schwab J; Choy E; Nielsen GP; Rosenthal DI
    Spine (Phila Pa 1976); 2017 Jan; 42(1):E37-E40. PubMed ID: 27254658
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Analysis of radiological features relative to histopathology in 42 skull-base chordomas and chondrosarcomas.
    Pamir MN; Ozduman K
    Eur J Radiol; 2006 Jun; 58(3):461-70. PubMed ID: 16631334
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1.
    Scheil S; Brüderlein S; Liehr T; Starke H; Herms J; Schulte M; Möller P
    Genes Chromosomes Cancer; 2001 Nov; 32(3):203-11. PubMed ID: 11579460
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Differential proteomic profiling of primary and recurrent chordomas.
    Chen S; Xu W; Jiao J; Jiang D; Liu J; Chen T; Wan Z; Xu L; Zhou Z; Xiao J
    Oncol Rep; 2015 May; 33(5):2207-18. PubMed ID: 25738923
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A brief review of chordomas: pathogenesis, prognostic factors and therapeutic targets.
    Hai B; Ma Y; Liu X
    Histol Histopathol; 2019 May; 34(5):445-456. PubMed ID: 30600829
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Advances in the development of chordoma models for drug discovery and precision medicine.
    Walker RL; Hornicek FJ; Duan Z
    Biochim Biophys Acta Rev Cancer; 2022 Nov; 1877(6):188812. PubMed ID: 36195275
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identifying mechanisms for therapeutic intervention in chordoma: c-Met oncoprotein.
    Ostroumov E; Hunter CJ
    Spine (Phila Pa 1976); 2008 Dec; 33(25):2774-80. PubMed ID: 19050584
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma.
    Mito I; Takahashi H; Kawabata-Iwakawa R; Ida S; Tada H; Chikamatsu K
    Sci Rep; 2021 Aug; 11(1):16134. PubMed ID: 34373557
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Immune Microenvironment of Chordomas: An Immunohistochemical Analysis.
    Dridi M; Krebs-Drouot L; Meyronet D; Dumollard JM; Vassal F; Jouanneau E; Jacquesson T; Barrey C; Grange S; Boutonnat J; Péoc'h M; Karpathiou G
    Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34283048
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Contemporary management of clival chordomas.
    Campbell RG; Prevedello DM; Ditzel Filho L; Otto BA; Carrau RL
    Curr Opin Otolaryngol Head Neck Surg; 2015 Apr; 23(2):153-61. PubMed ID: 25692630
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tumor-biology and current treatment of skull-base chordomas.
    Pamir MN; Ozduman K
    Adv Tech Stand Neurosurg; 2008; 33():35-129. PubMed ID: 18383812
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Revisiting chordoma with brachyury, a "new age" marker: analysis of a validation study on 51 cases.
    Jambhekar NA; Rekhi B; Thorat K; Dikshit R; Agrawal M; Puri A
    Arch Pathol Lab Med; 2010 Aug; 134(8):1181-7. PubMed ID: 20670140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.